Entity
Description
  • Value proposition

    Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development.

    Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.

Corporate interactions BETA
Corporate TypeTweets Articles
Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

1 Nov 2024


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

16 May 2023


WILCO
WILCO
Software Development
WILCO
Software Development
Other

15 Mar 2023


Gustave Roussy
Gustave Roussy
Health, Hospitals and Health Care
Gustave Roussy
Health, Hospitals and Health Care
Other

20 Sep 2024


Hello Tomorrow
Hello Tomorrow
Trade show, Business Consulting and Services
Hello Tomorrow
Trade show, Business Consulting and Services
Other

20 Mar 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

20 Sep 2024


Agoranov
Agoranov
Startup accelerator & VC, Technology, Information and Internet
Agoranov
Startup accelerator & VC, Technology, Information and Internet
Other

30 Sep 2024


Similar entities
Loading...
Loading...
Social network dynamics